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Abstract 15 
Mycotoxins exposure by inhalation and/or dermal contact can occur in different branches of industry especially where 16 
heavily dusty settings are present and the handling of dusty commodities is performed. This study aims to explore the 17 
possible contribution of the occupational exposure to aflatoxins by analysing urine samples for the presence of 18 
aflatoxins B1 and M1 and aflatoxin B1-N7-Guanine adduct. The study was conducted in 2017 on two groups of 19 
volunteers, the workers group, composed by personnel employed in an Italian feed plant (n=32), and a control group 20 
(n=29), composed by the administrative employees of the same feed plant; a total of 120 urine samples were collected 21 
and analysed. A screening method and a quantitative method with high resolution mass spectrometry determination 22 
were developed and fully validated. Limit of detections were 0.8 and 1.5 pg/mLurine for aflatoxin B1 and M1, 23 
respectively. No quantitative determination was possible for the adduct aflatoxin B1-N7-Guanine. Aflatoxin B1 and its 24 
adduct were not detected in the analysed samples, aflatoxin M1, instead, was found in 14 samples (12%) within the 25 
range 1.9-10.5 pg/mLurine. Only one sample showed a value above the limit of quantification (10.5 pg/mLurine). The 26 
absence of a statistical difference between the mean values for workers and the control group were compared suggests 27 
that in this specific setting, no professional exposure occurs. Furthermore, considering the very low level of aflatoxin 28 
M1 in the collected urine samples, also the contribution from the diet to the overall exposure is to be considered 29 
negligible. 30 
Manuscript Click here to
access/download;Manuscript;DeSantis_Manuscript_3RD_clea
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
 31 
Keywords 32 
Biomonitoring, Biomarker, Mycotoxin, Aflatoxin, Metabolites, LC-Orbitrap, LC-HRMS 33 
 34 
 35 
Introduction 36 
Among xenobiotics, mycotoxins, secondary metabolites of fungal origin, are the most harmful hazards with high toxic 37 
potency and recognized adverse impacts on human and animal health. More than 500 mycotoxins are known, but 38 
scientific studies focus on those that exert carcinogenic and/or toxic activity, and only few of them are regulated 39 
worldwide (Stein et al. 2017; CAST 2003; FAO 2004). Among mycotoxins, aflatoxins (AFs) represent one of the most 40 
concerning class of chemical compounds with a focus of interest on aflatoxin B1 (AFB1) that, due to its acute and 41 
chronic toxic effects, have raised the interest of the scientific community. The primary target organ affected by aflatoxin 42 
B1 exposure is the liver, and several epidemiological studies related AFB1 exposure to cellular hepatocarcinoma, report 43 
it as one of the major cause of cancer-related deaths in different parts of the world (Wild and Turner 2002). AFB1 is a 44 
genotoxic and carcinogenic substance, classified under group 1 by the International Agency for Research on Cancer 45 
(IARC 1993). AFs can occur in crops at pre-harvest, harvest and post-harvest stages as a result of different co-occurring 46 
environmental conditions and poor management practices (handling and storage). The expected global warming of +2 47 
°C is likely to cause a sensible climate change leading to conducive environmental conditions for AFs production in 48 
Northern-Europe, where currently no occurrence is significantly present (Battilani et al. 2016). Therefore, validating 49 
new methods for AFs determination becomes particularly relevant to be applied in newly exposed geographical regions. 50 
The most common route of exposure to mycotoxins is the ingestion through the diet due to the consumption of directly 51 
or indirectly contaminated food. Furthermore, humans and animals can also be exposed to mycotoxins through 52 
inhalation and/or dermal contact with contaminated dusts (Brera et al. 2002; Doi and Uetsuka 2014; Viegas et al. 2014, 53 
2017). Several studies reported a higher prevalence of lung carcinogenesis and bronchus and trachea tumours in 54 
workers exposed to aflatoxins contaminated dusts (McLaughlin et al. 1987; Olsen et al. 1988; Ghosh et al. 1997; Saad-55 
Hussein et al. 2013, 2014), especially in branches of industry where the storage, loading, milling and handling of dusty 56 
commodities (such as grains, feed, spices, coffee, etc.) is performed. Due to their severe toxicological implications, 57 
exposure to aflatoxins must be characterized by an accurate evaluation. Commonly, two different approaches can be 58 
followed for targeting this issue: via dietary exposure assessment and/or via biomonitoring studies. The overall 59 
metabolic pathway of AFB1 is quite complex and corresponds to the formation of a number of metabolites that could be 60 
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associated not only to the dose of the parent mycotoxin, but also to the biological response to the exposure and to the 61 
degree of individual sensitivity to adsorption and metabolism of the toxic agent (Groopman 1994). Validated exposure 62 
biomarkers for AFB1 (urinary aflatoxin M1, AFB1–N7-Guanine) were established almost 20 years ago (Groopman et al. 63 
1993), they were critical in confirming aflatoxins as potent liver carcinogens, and more importantly, they are being used 64 
to assess the effectiveness of intervention strategies (Cramer and Uetsuka 2017; Turner et al. 2012). 65 
Biomonitoring studies have been increased over the last 8 years. In a recent publication Viegas (Viegas et al. 2018) 66 
reviewed the use of biomonitoring in assessing occupational exposure to mycotoxin in different settings and 58% of the 67 
reviewed works assessed aflatoxins exposure. Despite the impossibility to distinguish between dietary and air-dust 68 
contamination, the literature review clearly showed that, under certain circumstances, workers were significantly more 69 
exposed than the control group (Malik et al. 2014; Saad-Hussein et al. 2014; Viegas et al. 2016). In Italy a first study on 70 
occupational exposure to aflatoxins was conducted in 2014 in two feed companies, to assess if workers occupied in 71 
dusty indoor settings were differently exposed than workers occupied in administrative units (control group) (Ferri et al. 72 
2017). To monitor the situation and to assess the effect of new agricultural season, the same scheme of the study was 73 
replicated in 2017 within a different analytical framework, where also the guanine metabolite was included. 74 
The present study aims to explore the role of the occupational exposure to aflatoxins by analysing urine samples to 75 
assess the presence of aflatoxins B1 and M1 and aflatoxin B1-N7-Guanine adduct in a group of workers, operating in 76 
risky workplaces, and a control group. The group of volunteer workers, operating in a setting of the feed sector, 77 
potentially exposed to mycotoxins through the inhalation of contaminated dust and/or by dermal contact and a control 78 
group, composed by administrative employees working on the same feed plant, were enrolled in the study. 79 
Aflatoxins determination was performed by a high-resolution mass spectrometry (LC-HRMS) technique. For sample 80 
preparation, a dilute&shoot method and a quantitative method based on immunoaffinity column purification step were 81 
developed and fully validated. Moreover, due to the unavailability of commercial standard of AFB1-N7-Guanine, the 82 
adduct was synthetized and used for the method set up and for qualitative analysis (presence/absence) in the collected 83 
samples. 84 
 85 
Materials and Methods 86 
Chemicals and reagents 87 
Chemicals and solvents used for sample preparation were LC-MS grade. Methanol, formic acid and LC–MS grade 88 
water were purchased from Fisher Scientific (Milano, Italy), AFB1 from Aspergillus flavus (purity ≥98%) was from 89 
Sigma-Aldrich (Darmstadt, Germany). The analytical reference standard of AFM1 was purchased as stock solution (0.5 90 
µg/mL in acetonitrile) from Biopure® (Tulln, Austria). The isotopically labelled internal standards U-[13C17]-AFB1 91 
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(99.3% 13C) and U-[13C17]-AFM1 (98.3% 13C) were also purchased as acetonitrile solution (0.5 µg/mL) from Biopure® 92 
(Tulln, Austria). The concentration reported in the certificate accompanying the reference standard purchased as 93 
solution was considered for quantification purpose. The AFB1 powder was reconstituted with 100% ACN and the 94 
concentration was assessed by molar absorbance value following the procedure reported in the official Methods of 95 
Analysis of AOAC (AOAC 2005). The AFB1-N7-Guanine adduct was not commercially available at the moment of the 96 
study and was synthetized as reported below. 97 
 98 
AFB1-N7-Guanine adduct synthesis and identification 99 
The synthesis was conducted accordingly with Vidyasagar et al. (1997) as follows: meta-chloroperoxybenzoic acid 100 
(MCPBA), 20 mg in 4 mL of dichloromethane, was washed with 100 mM mmol/L phosphate buffer, pH 7.4 (4 mL x 4). 101 
The resulting MCPBA solution was passed through anhydrous sodium sulphate to remove residual water. AFB1 (0.64 102 
µmol) was dissolved in 250 µL of dichloromethane and was converted to AFB1-8,9-epoxide by addition of 250 µL of 103 
the above MCPBA solution (4 µmol) and 500 µL of 100 mM mmol/L phosphate buffer, pH 7.2. The reaction was 104 
carried out at 5 °C for 100 min with continuous vigorous stirring. At the end of 100 min the buffer fraction was pipetted 105 
out. 0.32 µmol of Guanine, previously dissolved in 0.1 mol/L HCl, were added to 500 µL of 100 mM mmol/L 106 
phosphate buffer, pH 7.4 (maximum solubility of guanine in phosphate buffer was found to be 140 µg/mL). The buffer 107 
with guanine was added to the tube containing AFB1-8,9-epoxide in dichloromethane and the reaction was continued 108 
for 60 min at 5 °C with continuous vigorous stirring. At the end of 60 min the reaction mixture was centrifuged at 4000 109 
rpm for 5 min. The organic phase was separated and the buffer fraction was repeatedly washed with dichloromethane 110 
(500 µL x 3 times). The adduct identification was based on the observation of the molecular ion and at least one 111 
fragment specific for the analyte after injection in the LC-HRMS system, according to the guidance document on 112 
identification of mycotoxins in food and feed (EC 2016). Due to the difficulties in assessing the concentration level of 113 
the synthetized adduct, the diluted buffer fraction was used for testing the IAC cross reactivity during method 114 
development and for a qualitative evaluation of presence/absence in the collected urine samples. 115 
 116 
Study design 117 
The investigation was conducted in the same feedstuff plant involved in the first study previously published by Ferri et 118 
al. (2017). This second study was conducted within the framework of a larger project entitled “Biomonitoring data as a 119 
tool for assessing aflatoxin B1 exposure of workers – BIODAF” supported by EFSA (July 2017 - June 2018). The 120 
project focused on aflatoxins and took into consideration urine and serum samples collection and analysis. Two 121 
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countries, Italy and Portugal, were involved in this study. The present paper reports the results obtained from the Italian 122 
urine analyses. 123 
Two groups of volunteers were enrolled, the “workers group”, corresponding to all workers in direct contact with some 124 
risky activities such as the downloading of the raw material, its handling and the cleaning procedures; and the “control 125 
group”, which included employees of the same company but designated to perform other activities considered not risky 126 
for the absence of contaminated environmental dusts. The samples were collected on Monday and Friday morning in 127 
one working week, Monday was chosen since it reflects a situation characterized by a preceding two-days washing 128 
period and Friday was selected with the aim to verify a possible accumulation of AFs and consequent intake over the 129 
week of sampling. The urine was collected in the morning and delivered to the medical staff before starting the morning 130 
shift. A total of 61 male volunteers were enrolled (32 workers and 29 controls). The collected urine samples were stored 131 
at -20 °C until analysis. The mean value and range for age and body weight of the enrolled volunteers are reported in 132 
Table 1. 133 
The study was conducted under the supervision of the Local Health Unit of Reggio Emilia and was approved by the 134 
Ethical Committee of the Reggio Emilia province. All urine donors were informed about the purpose of the study and a 135 
formal consent was individually signed prior to inclusion in the study. 136 
 137 
Sample preparation 138 
Dilute&shoot sample preparation 139 
Before analysis, all urine samples were equilibrated to room temperature and homogenized by shaking thoroughly. 140 
Aliquots of 100 µL urine were mixed with 860 µL of H2O LC-MS grade; for quantification purpose 20 µL of U-[13C17]-141 
AFB1 5 ng/mL in acetonitrile and 20 µL of U-[13C17]-AFM1 10 ng/mL in acetonitrile were added to the sample. The 142 
diluted sample was centrifuged for 10 minutes at 3500 x g (RCF) before the injection of 10 µL into the UHPLC-HRMS 143 
system. 144 
 145 
Immunoaffinity clean-up 146 
Before analysis, all urine samples were equilibrated to room temperature and homogenized by shaking thoroughly. 147 
Aliquots of 2 mL urine were mixed with 10 mL of phosphate buffered solution (PBS, pH=7.4) and passed through the 148 
immunoaffinity column (IAC) for purification (Easy-extract® aflatoxins, from R-Biopharm, Darmstadt, Germany). The 149 
IAC was washed with 30 mL of H2O (10+10+10 mL), then the toxins were eluted with 1 mL of MeOH (500+500 µL). 150 
Finally, 500 µL of eluted sample were added with 20 µL U-[13C17]-AFB1 2.5 ng/mL in ACN, 20 µL U-[13C17]-AFM1 5 151 
ng/mL in ACN and 460 µL of H2O. A volume of 20 µL was injected into the UHPLC-HRMS system. 152 
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 153 
LC-HRMS Analysis 154 
Determination was performed by UHPLC-HRMS analysis. Chromatographic separation was performed using UHPLC 155 
Dionex UltiMate 3000® (Thermo Scientific, San Jose, CA, USA). An Acquity UPLC® BEH C18 column (1.7 µm, 100 156 
× 2.1 mm, from Waters, Milford, MA, USA) was used at a temperature of 40 °C. The flow rate was 0.3 mL/min, mobile 157 
phases A and B were respectively water and methanol containing 0.002% formic acid (v/v) and 2 mM mmol/L 158 
ammonium formate. The following gradient was applied: 20% B increase to 99% in 10 min, keep isocratic at 99% B for 159 
4 min, from 14 to 14.6 min return to 20% B, and finally re-equilibrate the column at 20% B for 2.4 min. High-resolution 160 
MS analysis was performed using Q Exactive™ Quadrupole-Orbitrap™ equipped with Heated ElectroSpray Ionization 161 
(HESI) source (Thermo Scientific, San Jose, CA, USA). The following ESI (+) parameters were used: source voltage 162 
3.5 kV, in-source CID 18 eV, capillary temperature 320 °C, auxiliary gas heater temperature 350 ° C, sheath gas flow 163 
40, S-lens RF level 75 and auxiliary gas flow 14. The MS acquisition was performed in Full Scan/Data Dependent (full 164 
MS/dd-MS2) for confirmatory purpose. Precursor ion, fragments and collision energy used for the determination of the 165 
selected mycotoxins are reported in Table 2. All analytical batches included analysis of appropriate extraction and 166 
solvent blanks, solvent calibration curves at the beginning and end of the analytical batch, and injection of a calibration 167 
level every 10 sample injections to ensure LC–MS stability throughout the run. For data acquisition and processing, 168 
Xcalibur™ software 4.0.27.19 was used. 169 
 170 
Analytical quantification 171 
For mycotoxins quantification an internal standard (ISTD) approach was adopted. The internal standard for AFB1 and 172 
AFM1 was the 13C isotope labelled molecule in which all carbon atoms are substituted by the stable isotope 13C. Six 173 
points calibration curve was obtained by plotting the response ratio (standard area/13C area) versus the concentration 174 
expressed in pg/mLurine. The concentration ranges covered for dilute&shoot method were 5-100 pg/mL for AFB1 and 175 
10-200 pg/mL for AFM1, corresponding to 50-1000 pg/mLurine and 100-2000 pg/mLurine for AFB1 and AFM1, 176 
respectively. For IAC method the ranges were 5-50 pg/mL for AFB1 and 10-100 pg/mL for AFM1, corresponding to 177 
2.5-25 pg/mLurine and 5-50 pg/mLurine for AFB1 and AFM1, respectively. The calibration curve was obtained by fitting 178 
the data with a linear regression model based on least squares method. 179 
 180 
Validation criteria 181 
Identification criteria were set for all the analysed mycotoxins. Linearity and limit of detection (LOD) and 182 
quantification (LOQ) of the analytical methods were assessed. Precision and trueness were assessed from repeated 183 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
 
analyses on spiked blank urine samples. Precision was evaluated by calculating the intermediate relative standard 184 
deviation (repeated analyses on different days), while trueness was estimated in terms of apparent recovery (RA). 185 
Extraction efficiency (RE) and matrix effect (SSE) were also evaluated for validation purpose. 186 
 187 
Method validation 188 
For both methods, linearity of the method was evaluated from six points calibration curves injected in triplicate for three 189 
consecutive days. Regression lines were plotted applying a linear regression model based on least squares method. The 190 
linearity was assessed by visual checking of the residual plot of response ratios (plotted in y-direction) versus the 191 
respective concentration levels (plotted in x-direction). The final estimated linearity model was verified using the lack-192 
of-fit test (significance of the test with pvalue below 0.05), to confirm that the selected regression and linearity were 193 
acceptable. Once visual checking of the residual and lack-of-fit test passed, the R squared coefficient was taken as a 194 
measure of linearity. 195 
According to the criteria reported in the SANTE/12089/2016 guidance document on identification of mycotoxins in 196 
food and feed (EC 2016), the retention time (RT) of the analyte in the sample extract should correspond to that of the 197 
average of the calibration standards measured in the same sequence with a tolerance of ± 0.1 min. Moreover, for the 198 
ISTD added to the sample extract, the RT of the analyte should correspond to that of its labelled ISTD with a tolerance 199 
of ±0.05 min. For HRMS analysis identification is based on observation of the molecular ion (or, if not available, 200 
adducts) and one fragment that is specific for the selected analyte. 201 
According to Wenzl et al. (2016), spiked blanks approach was used for LOD and LOQ assessment, by analysing the 202 
spiked sample in ten replicates under repeatability conditions. The variability expressed as standard deviation obtained 203 
for the ten analyses of spiked blanks was used for the estimation of the critical value of LOD. Calculations were carried 204 
out according to Equation 1 and 2. 205 
 206 
𝑥𝐿𝑂𝐷 = 3.9 ×
𝑠𝑦,𝑏
𝑏
 (1) 207 
𝑥𝐿𝑂𝑄 = 3.3 × 𝑥𝐿𝑂𝐷  (2) 208 
 209 
The LOQ values obtained with the theoretical calculation approaches were included in the validation as the lowest 210 
concentration level. 211 
For dilute&shoot method, the matrix effect was examined according to Sulyok et al. (2006) assessing the matrix 212 
induced enhancement or suppression during analysis. For this purpose, calibration curves in solvent (5 calibration points 213 
in the range of 40-200 pg/mL for AFB1 and 80-400 pg/mL for AFM1, constructed by plotting signal intensity versus the 214 
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analyte concentration) were compared with matrix-matched calibration curves (blank sample 1:10 diluted spiked at 5 215 
levels, curves obtained by plotting the signal intensity against the actual spiking level). The slopes of the resulting 216 
calibration curves were used for signal suppression/enhancement (SSE) calculation (Equation 3). 217 
 218 
SSE(%) = 100 ∗
slope (matrix−matched standard)
slope (solvent standard)
  (3) 219 
 220 
For IAC method, apparent recovery, matrix effect and extraction recovery were assessed on 5 different levels of 221 
contamination, including the calculated LOQ values, for each level triplicate analyses of spiked blank sample on 2 222 
consecutive days were performed. The obtained data were used for apparent recovery (RA), matrix effect and extraction 223 
recovery (RE) calculations and for precision assessment. The RA is calculated as the ratio between the slope of the 224 
spiked sample curve, obtained from the spiked samples, and the slope of the calibration curve in pure solvent (Equation 225 
4). In this case, the curves were obtained considering the area and not the ratio with the labelled internal standard added 226 
for each mycotoxin. The RA represents the influence of the whole analytical process (sample preparation + 227 
determination) on the signal and it is also referred to as overall or total recovery of a method. RA was the parameter 228 
used for trueness evaluation. 229 
 230 
RA(%) = 100 ∗
slope (spiked sample)
slope (solvent standard)
  (4) 231 
 232 
The matrix effect was evaluated in terms of Signal Suppression/Enhancement (SSE) and it was calculated, according to 233 
Equation 5, as the ratio between the mean area of the labelled ISTD in the spiked sample extract and in the pure solvent 234 
standard solution. 235 
 236 
𝑆𝑆𝐸 (%) = 100 ×
𝑎𝑟𝑒𝑎 𝑈−[13𝐶17]−𝐴𝐹𝐵1𝑠𝑎𝑚𝑝𝑙𝑒
𝑎𝑟𝑒𝑎 𝑈−[13𝐶17]−𝐴𝐹𝐵1𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑
  (5) 237 
 238 
The RE, accounting to incomplete extraction of the analyte from the matrix, was calculated from RA and SSE, according 239 
to Equation 6. 240 
 241 
RE(%) = 100 ∗
RA
SSE
  (6) 242 
 243 
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The effect of random errors on the measurements were assessed and quantified as the relative standard deviation (RSD) 244 
of repeated independent analyses conducted in intermediate conditions of repeatability within the laboratory (RSDLR). 245 
Instrumental laboratory reproducibility of the LC-HRMS system was also evaluated by injecting on three consecutive 246 
days (inter-run) and in replicates (intra-run) a neat solvent standard solution (AFB1 150 pg/mL and AFM1 300 pg/mL). 247 
Moreover, the intermediate precision of the whole method was evaluated by analyzing daily independent urine sample 248 
spiked at the same contamination level as an internal control sample (inter-day). The performance criteria for precision, 249 
quantified with standard deviation of repeatability within the laboratory (sLR) and expressed in percentage as RSDLR, 250 
was set at 15% of variability, including any source of instrumental and analytical possible random errors. Precision was 251 
estimated in terms of intermediate precision RSDLR of repeatability. 252 
 253 
Results and Discussion 254 
Sample preparation and LC-HRMS analysis 255 
During method set up two urine:water dilution factors, namely 1:5 and 1:10, were tested for dilute&shoot approach. The 256 
1:10 dilution gave better results in terms of SSE and was selected for the analysis. The IAC purification step was 257 
introduced in order to reduce the LOD/LOQ values. The employed IAC contains specific antibodies to aflatoxins B1, 258 
B2, G1, G2 and M1, no specific information was given by the supplier for AFB1-N7-Guanine. To evaluate the risk of 259 
adduct loss during purification, the synthetized adduct was applied to the IAC, eluted according to method protocol and 260 
the presence of the adduct was confirmed by LC-HRMS identification. 261 
HRMS conditions were set by direct infusion of standard solution for AFB1 and AFM1, while for AFB1-N7-Guanine the 262 
selection of collision energy and specific fragments were guided by the work of Walton et al. (2001). AFB1 produces 263 
sodiated adduct in a non negligible amount when compared with protonated adduct during electrospray ionization step, 264 
although AFB1 is unlikely produce ammonium adduct, the presence of the ammonium in the mobile phase suppresses 265 
the sodiated adduct in favour of the protonated one. This is the reason for the presence in the mobile phases of formic 266 
acid and ammonium formate. For quantitative purpose the protonated adducts were selected, for AFM1, since it was not 267 
possible to reduce the sodiated adduct production by varying source parameters, the sum of the protonated and sodiated 268 
adduct was considered. 269 
 270 
Validation parameters 271 
Linearity was checked in the working range by the lack-of-fit test based on the analysis of variance (F test with p value 272 
<0.05) and the plot of the residual values randomly distributed around zero, confirming the linearity. During routine 273 
analytical sessions an R2 >0.990 was set as a criterion for calibration curve acceptability. In Table 3 the calibration 274 
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curve ranges, the amount of ISTD added to each calibration level and the correlation coefficients (R2) obtained for each 275 
mycotoxin/matrix combination are reported. 276 
The performance characteristics, in terms of RA, SSE and RE, are summarized in Table 4 together with LOD and LOQ 277 
values and the working range of the two analytical procedures. Both methods may be applied for quantitative analysis 278 
of AFB1 and AFM1 as well as for the evaluation of presence/absence of the AFB1-N7-Guanine adduct. The dilute&shoot 279 
method is characterized by higher LOD and LOQ values when compared with the IAC clean-up method, but on the 280 
other hand the dilute&shoot approach is very quick and characterized by a conservative approach with respect to the 281 
sample, giving the possibility of a retrospective analysis on the acquired data. Due to the absence of a sample pre-282 
treatment only matrix effect, in terms of SSE, and precision, in terms of RSDLR, were evaluated during dilute&shoot 283 
method validation. SSE percentages are very close to 100% due to the dilution applied to the urine sample; method 284 
precision was assessed by performing 8 independent analyses at the LOQ level. The IAC clean-up method was fully 285 
validated, trueness was evaluated in terms of apparent recovery (RA) while precision was assessed by laboratory 286 
reproducibility RSDLR measures. Although the IAC clean-up, which is a very selective approach, was used, the 287 
influence of the matrix was also evaluated, and the percentages of SSE for AFB1 and AFM1 found confirmed that the 288 
influence of the matrix on the instrumental response is very limited.  289 
LOD and LOQ of analytical methods always represent a challenge being the bottleneck for the reliability of the 290 
analytical results and also for the further processing of the findings (i.e. data mining). Modern HRMS instruments 291 
makes it possible to reach high sensitivities with low detection limits, and especially when methods are targeted, good 292 
benchmarks can be achieved. Among the most recent studies on the biomonitoring of aflatoxins, the lowest values for 293 
AFM1 were found in the range of 0.13-0.6 pg/mLurine and in the 0.4-1.8 pg/mLurine for LOD and LOQ, respectively 294 
(Giolo et al. 2012; Romero et al. 2010). Although these values represent a gold standard benchmark, they are not 295 
covered by the strict performance requirements of accuracy, which instead were met at 10 pg/mLurine (Giolo et al. 2012) 296 
and 4 pg/mLurine (Romero et al. 2010). Thus, the LOD/LOQ values obtained in the IAC method, validated under strict 297 
performances, are in alignment with the findings in other bomonitoring works for AFM1. Notwithstanding, all the 298 
positive samples were in the range of values between LOD and LOQ, revealing the crucial need to stress the method to 299 
reach lower levels. In conclusion, the general validation results obtained in this study are considered satisfactory either 300 
for screening and for confirmation and the method is considered to suit for the production accurate data for 301 
biomonitoring purposes. 302 
 303 
Analytical results 304 
Statistical analysis and Data handling - Left censored data 305 
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The hypothesis of normal distribution (Shapiro–Wilk test) was refused, thus non-parametrical tests were used for the 306 
statistical treatment of the analytical results. All possible differences between concentration levels of mycotoxins in 307 
exposed and non-exposed groups were explored by a Wilcoxon rank-sum test. To assess the correlation between 308 
mycotoxin levels, a Spearman’s rank correlation coefficient (or Spearman’s rho) was used. All tests were conducted 309 
with a level of significance of 5%. Analyses were conducted by means of STATA14 software (Stata/IC 14.0, Copyright 310 
1985–2015 StataCorp LP). Under the rigid identification criteria for analyte determination, namely the RT criteria 311 
(RT±0.1 min with respect to the standard RT) and the presence of the precursor ion and at least one characteristic 312 
fragment for each considered analyte, it was decided to include and report also all the values below LOQ obtained by 313 
the interpolation of the calibration curve. Thus, values lower than LOQ were reported in the dataset as positive samples 314 
provided that the identification criteria were met. The results evaluation included also the reporting of the lower and 315 
upper bound (LB and UB) mean values (EFSA 2010). These values were calculated applying a substitution method for 316 
which in the LB calculations the results lower than LOQ were substituted with zero, while in the UB the results lower 317 
than LOQ were substituted with LOQ value depending on the method. 318 
 319 
Analysis of samples 320 
The collected urine samples were analysed first with the dilute&shoot method, through which none of the sample 321 
showed a measurable level of AFB1 or AFM1, including AFB1-N7-Guanine which was not detected. To overcome the 322 
limitations coming from the detection limit threshold of the dilute&shoot method and verify that the negativity of the 323 
results could be caused by the level of LOD/LOQ declared, it was decided to set up and validate a method with lower 324 
LOQ. A purification step was introduced using an IAC clean-up to clean and concentrate the urine sample. By using 325 
this method for reprocessing the urine samples, AFB1 and its adduct were not detected, AFM1, instead, was found in 14 326 
samples (12%) within the range 1.9-10.5 pg/mLurine. Only one sample, coming from the workers’ group, showed a value 327 
above the LOQ (10.5 pg/mLurine) and it is a sample from the workers group. Tables 5 and 6 summarize the percentages 328 
of positive samples, maximum values found, and mean values (LB-UB) for worker and control groups, respectively. It 329 
should be noted that when values reported for AFM1 are below the LOQ they were considered as affected by a standard 330 
uncertainty higher than 25%, which was the performance criteria set for maximum standard uncertainty for the LOQ. 331 
The LB-UB values reflect the optimistic and pessimistic scenario range of possible mean values. 332 
Figure 1 shows the data trend for AFM1 in urine for both groups, Monday and Friday sampling. On the left side LB 333 
substitution method was applied, due to the high number of non-detected (87%), box plot is flattened to zero. On the 334 
right side the box plot reports all the positive values are reported. The band inside the box is the second quartile (P50, 335 
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median). Dots indicates suspected outliers. Whiskers are set from minimum to maximum value. First and third quartiles 336 
(P25 and P75) can be found at the bottom and the top of the box, respectively. 337 
No statistical difference for AFM1 was observed between Monday and Friday samples in each group (exposed and non-338 
exposed workers). To note that among the positive results two individuals of the exposed workers group showed AFM1 339 
in both Monday and Friday deliveries (3.3 and 3.0 pg/mLurine and 4.6 and 10.5 pg/mLurine, Monday and Friday values for 340 
each individual, respectively. Further statistical analyses were performed merging data of Monday and Friday data (63 341 
analyses for exposed workers group and 57 for non-exposed workers group). Eight samples (13%) resulted positive in 342 
the workers’ group where the highest contaminated sample was found (10.5 pg/mLurine); six samples (11%) were 343 
positive in the control group, the higher detected value was 4.1 pg/mLurine. In order to find differences among the 344 
positive values found in workers and control group, a Wilcoxon rank-sum test was performed but no statistical 345 
significances were highlighted; even exploring the two days of urine delivery, no differences were highlighted. 346 
The absence of AFB1 and its adduct, together with the absence of a statistical difference when the mean values of AFM1 347 
for workers and control groups were compared, suggests that in this specific setting, no professional exposure occurs. 348 
Moreover, considering the very low level of AFM1 in the collected urine samples, also the contribution from the diet to 349 
the overall exposure is to be considered negligible. 350 
This study presents a method, performed by a high-resolution mass spectrometry (LC-HRMS) technique, to detect 351 
AFB1 and aflatoxin biomarkers, namely AFM1 and aflatoxin-N7-Guanine. If compared with the previous study 352 
conducted in 2014 (Ferri et al. 2017), the present work tackles with an improvement of method sensitivity (1.5 353 
pg/mLurine versus 25 pg/mLurine in Ferri et al. (2017). High percentages of workers positive for AFB1 were reported in 354 
several studies conducted in EU (Portugal, Italy, Denmark) (Olsen et al. 1988; Viegas et al. 2018; Ferri et al. 2017) 355 
emphasizing that occupational exposure might be critical in certain settings, such as feed plants, in which indoor areas 356 
can be conducive of highly contaminated dust particles. In this study, morning urine samples were collected during one 357 
working week from a cohort of occupational exposed workers of a feed company and from a control group. The 358 
presence of only one positive sample of AFB1 and the lack of statistical difference between mean values of AFM1 in 359 
workers and control groups, suggests that in this specific setting, the primary route of exposure to AFs is more likely to 360 
be attributed to the diet and not to the respiratory route when inhalation or dermal contact of aerosolized contaminated 361 
dusts occur. However, the attention and focus to AFs can’t never be reduced to a no-risk situation, since, due to the 362 
direct correlation between aflatoxins occurrence and climate changes, a systematic monitoring of the health status of 363 
citizen (including workers) potentially exposed to dusts contaminated by these toxic compounds, has to be duly 364 
undertaken. 365 
 366 
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Figure 1 Data trend for AFM1 in urine for exposed and control groups. Left side, mean LB values; right side, mean 486 
positive values. The horizontal band (inside the box) is the second quartile (P50, median). Dots are suspected outliers. 487 
Whiskers are set from minimum to maximum value. The bottom and the top of the box are the first and third quartiles 488 
(P25 and P75). 489 
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Table 1. Distribution of the enrolled volunteers by group, age and body weight 517 
Volunteers Number of subjects Mean age (range); years Mean body weight (range); kg 
Workers group 32 53 (32–65) 80.1 (62–99) 
Controls group 29 48 (33–63) 83.4 (64–125) 
Total 61 - - 
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Table 2 Precursor ion, fragments and collision energy used for the detection of the selected mycotoxins in 545 
urine samples 546 
Compound Chemical formula Precursor ion (m/z) [M+H]+ Fragment (m/z) NCEa 
AFB1 C17H12O6 313.07066 285.07571; 241.04952 25 
13C17-AFB1 C17H12O6 330.12770 - - 
AFM1 C17H12O7 329.06558 + 351.04752b 273.07538; 229.04937 27 
13C17-AFM1 C17H12O6 346.12261 + 368.10456b - - 
AFB1-N7-Guanine C22H17N5O8 480.11499 152.05678, 165.05499 40; 90 
aNormalised Collision Energy; b[M+Na]+ 547 
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Table 3 Calibration curve range, labelled internal standard concentration and correlation coefficients 572 
obtained for each mycotoxin/matrix combination are reported 573 
Method 
Calibration curve range 
(pg/mL) 
Labelled standard 
(pg/mL) 
R2 (RSD, %) 
 AFB1 AFM1 U-[13C17]-AFB1 U-[13C17]-AFM1 AFB1 AFM1 
Dilute&shoot 5–100 10–200 10 20 0.9965 (0.04) 0.9967 (0.20) 
IAC 2.5–50 5–100 50 100 0.9973 (0.09) 0.9976 (0.10) 
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Table 4 Performance characteristics obtained during validation for AFB1 and AFM1 in urine with 598 
dilute&shoot and IAC clean-up methods 599 
 Dilute&shoot method IAC clean-up method 
 AFB1 AFM1 AFB1 AFM1 
LOD (pg/mLurine) 20 40 0.8 1.5 
LOQ (pg/mLurine) 50 100 2.5 5.0 
Working range 
(pg/mLurine) 
50.0–1000.0 100.0–2000.0 2.5–25.0 5.0–50.0 
RA (%) - - 101 98 
RE (%) - - 97 92 
SSE (%) 82 111 104 107 
RSDr (%) 8 11 6 12 
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Table 5. Percentage of positive samples, maximum values found and mean values (LB-UB) for AFM1 in workers group 622 
samples 623 
 Positivea (%) Maxb (pg/mLurine) Mean (LB-UB) (pg/mLurine) 
Monday and Friday; subjects (n=63) 13 10.5 0.5-4.9 
Monday; subjects (n=32) 13 4.6c 0.4-4.48 
Friday; subjects (n=31) 13 10.5 0.6-5.0 
aPositive: values above LOD 624 
bMax: maximum value 625 
cvalue below the LOQ 626 
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Table 6. Percentage of positive samples, maximum values found and mean values (LB-UB) for AFM1 in controls group 651 
samples 652 
 Positivea (%) Maxb (pg/mLurine) Mean (LB-UB) (pg/mLurine) 
Monday and Friday; subjects (n=57) 11 4.1 0.3-4.8 
Monday; subjects (n=29) 7 2.8c 0.2-4.8 
Friday; subjects (n=28) 14 4.1c 0.4-4.7 
aPositive: values above LOD 653 
bMax: maximum value 654 
cvalue below the LOQ 655 
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 17 
Abstract 18 
Mycotoxins exposure by inhalation and/or dermal contact can occur in different branches of industry especially where 19 
heavily dusty settings are present and the handling of dusty commodities is performed. This study aims to explore the 20 
possible contribution of the occupational exposure to aflatoxins by analysing urine samples for the presence of 21 
aflatoxins B1 and M1 and aflatoxin B1-N7-Guanine adduct. The study was conducted in 2017 on two groups of 22 
volunteers, the workers group, composed by personnel employed in an Italian feed plant (n=32), and a control group 23 
(n=29), composed by the administrative employees of the same feed plant; a total of 120 urine samples were collected 24 
and analysed. A screening method and a quantitative method with high resolution mass spectrometry determination 25 
were developed and fully validated. Limit of detections were 0.8 and 1.5 pg/mLurine for aflatoxin B1 and M1, 26 
respectively. No quantitative determination was possible for the adduct aflatoxin B1-N7-Guanine. Aflatoxin B1 and its 27 
adduct were not detected in the analysed samples, aflatoxin M1, instead, was found in 14 samples (12%) within the 28 
range 1.9-10.5 pg/mLurine. Only one sample showed a value above the limit of quantification (10.5 pg/mLurine). The 29 
absence of a statistical difference between the mean values for workers and the control group were compared suggests 30 
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that in this specific setting, no professional exposure occurs. Furthermore, considering the very low level of aflatoxin 31 
M1 in the collected urine samples, also the contribution from the diet to the overall exposure is to be considered 32 
negligible. 33 
 34 
Keywords 35 
Biomonitoring, Biomarker, Mycotoxin, Aflatoxin, Metabolites, LC-Orbitrap, LC-HRMS 36 
 37 
 38 
Introduction 39 
Among xenobiotics, mycotoxins, secondary metabolites of fungal origin, are the most harmful hazards with high toxic 40 
potency and recognized adverse impacts on human and animal health. More than 500 mycotoxins are known, but 41 
scientific studies focus on those that exert carcinogenic and/or toxic activity, and only few of them are regulated 42 
worldwide (Stein et al. 2017; CAST 2003; FAO 2004). Among mycotoxins, aflatoxins (AFs) represent one of the most 43 
concerning class of chemical compounds with a focus of interest on aflatoxin B1 (AFB1) that, due to its acute and 44 
chronic toxic effects, have raised the interest of the scientific community. The primary target organ affected by aflatoxin 45 
B1 exposure is the liver, and several epidemiological studies related AFB1 exposure to cellular hepatocarcinoma, report 46 
it as one of the major cause of cancer-related deaths in different parts of the world (Wild et aland Turner. 2002). AFB1 47 
is a genotoxic and carcinogenic substance, classified under group 1 by the International Agency for Research on Cancer 48 
(IARC 1993). AFs can occur in crops at pre-harvest, harvest and post-harvest stages as a result of different co-occurring 49 
environmental conditions and poor management practices (handling and storage). The expected global warming of +2 50 
°C is likely to cause a sensible climate change leading to conducive environmental conditions for AFs production in 51 
Northern-Europe, where currently no occurrence is significantly present (Battilani et al. 2016). Therefore, validating 52 
new methods for AFs determination becomes particularly relevant to be applied in newly exposed geographical regions. 53 
The most common route of exposure to mycotoxins is the ingestion through the diet due to the consumption of directly 54 
or indirectly contaminated food. Furthermore, humans and animals can also be exposed to mycotoxins through 55 
inhalation and/or dermal contact with contaminated dusts (Brera et al. 2002; Doi and Uetsukaet al. 2014; Viegas et al. 56 
2014,; Viegas et al.  2017). Several studies reported a higher prevalence of lung carcinogenesis and bronchus and 57 
trachea tumours in workers exposed to aflatoxins contaminated dusts (McLaughlin et al. 1987; Olsen et al. 1988; Ghosh 58 
et al. 1997; Saad-Hussein et al. 2013,; Saad-Hussein et al. 2014), especially in branches of industry where the storage, 59 
loading, milling and handling of dusty commodities (such as grains, feed, spices, coffee, etc.) is performed. Due to their 60 
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severe toxicological implications, exposure to aflatoxins must be characterized by an accurate evaluation. Commonly, 61 
two different approaches can be followed for targeting this issue: via dietary exposure assessment and/or via 62 
biomonitoring studies. The overall metabolic pathway of AFB1 is quite complex and corresponds to the formation of a 63 
number of metabolites that could be associated not only to the dose of the parent mycotoxin, but also to the biological 64 
response to the exposure  and to the degree of individual sensitivity to adsorption and metabolism of the toxic agent 65 
(Groopman 1994). Validated exposure biomarkers for AFB1 (urinary aflatoxin M1, AFB1–N7-Guanine) were established 66 
almost 20 years ago (Groopman et al. 1993), they were critical in confirming aflatoxins as potent liver carcinogens, and 67 
more importantly, they are being used to assess the effectiveness of intervention strategies (Cramer et al.and Uetsuka 68 
2017; Turner et al. 2012). 69 
Biomonitoring studies have been increased over the last 8 years. In a recent publication Viegas (Viegas et al. 2018) 70 
reviewed the use of biomonitoring in assessing occupational exposure to mycotoxin in different settings and 58% of the 71 
reviewed works assessed aflatoxins exposure. Despite the impossibility to distinguish between dietary and air-dust 72 
contamination, the literature review clearly showed that, under certain circumstances, workers were significantly more 73 
exposed than the control group (Malik et al. 2014; Saad-Hussein et al. 2014; Viegas et al. 2016). In Italy a first study on 74 
occupational exposure to aflatoxins was conducted in 2014 in two feed companies, to assess if workers occupied in 75 
dusty indoor settings were differently exposed than workers occupied in administrative units (control group) (Ferri et 76 
al., 2017). To monitor the situation and to assess the effect of new agricultural season, the same scheme of the study 77 
was replicated in 2017 within a different analytical framework, where also the guanine metabolite was included. 78 
The present study aims to explore the role of the occupational exposure to aflatoxins by analysing urine samples to 79 
assess the presence of aflatoxins B1 and M1 and aflatoxin B1-N7-Guanine adduct in a group of workers, operating in 80 
risky workplaces, and a control group. The group of volunteer workers, operating in a setting of the feed sector, 81 
potentially exposed to mycotoxins through the inhalation of contaminated dust and/or by dermal contact and a control 82 
group, composed by administrative employees working on the same feed plant, were enrolled in the study. 83 
Aflatoxins determination was performed by a high-resolution mass spectrometry (LC-HRMS) technique. For sample 84 
preparation, a dilute&shoot method and a quantitative method based on immunoaffinity column purification step were 85 
developed and fully validated. Moreover, due to the unavailability of commercial standard of AFB1-N7-Guanine, the 86 
adduct was synthetized and used for the method set up and for qualitative analysis (presence/absence) in the collected 87 
samples. 88 
 89 
Materials and Methods 90 
Chemicals and reagents 91 
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Chemicals and solvents used for sample preparation were LC-MS grade. Methanol, formic acid and LC–MS grade 92 
water were purchased from Fisher Scientific (Milano, Italy), AFB1 from Aspergillus flavus (purity ≥98%) was from 93 
Sigma-Aldrich (Darmstadt, Germany). The analytical reference standard of AFM1 was purchased as stock solution (0.5 94 
µg/mL in acetonitrile) from Biopure® (Tulln, Austria). The isotopically labelled internal standards U-[13C17]-AFB1 95 
(99.3% 13C) and U-[13C17]-AFM1 (98.3% 13C) were also purchased as acetonitrile solution (0.5 µg/mL) from Biopure® 96 
(Tulln, Austria). The concentration reported in the certificate accompanying the reference standard purchased as 97 
solution was considered for quantification purpose. The AFB1 powder was reconstituted with 100% ACN and the 98 
concentration was assessed by molar absorbance value following the procedure reported in the official Methods of 99 
Analysis of AOAC (AOAC 2005). The AFB1-N7-Guanine adduct was not commercially available at the moment of the 100 
study and was synthetized as reported below. 101 
 102 
AFB1-N7-Guanine adduct synthesis and identification 103 
The synthesis was conducted accordingly with Vidyasagar et al. (1997) as follows: meta-chloroperoxybenzoic acid 104 
(MCPBA), 20 mg in 4 mL of dichloromethane, was washed with 100 mM mmol/L phosphate buffer, pH 7.4 (4 mL x 4). 105 
The resulting MCPBA solution was passed through anhydrous sodium sulphate to remove residual water. AFB1 (0.64 106 
µmoles) was dissolved in 250 µL of dichloromethane and was converted to AFB1-8,9-epoxide by addition of 250 µL of 107 
the above MCPBA solution (4 µmoles) and 500 µL of 100 mM mmol/L phosphate buffer, pH 7.2. The reaction was 108 
carried out at 5 °C for 100 min with continuous vigorous stirring. At the end of 100 min the buffer fraction was pipetted 109 
out. 0.32 µmoles of Guanine, previously dissolved in 0.1 mol/LN HCl, (0.32 µmoles) waswere added to  taken in 500 110 
µL of 100 mM mmol/L phosphate buffer, pH 7.4 (maximum solubility of guanine in phosphate buffer was found to be 111 
140 µg/mL). The buffer with guanine was added to the tube containing AFB1-8,9-epoxide in dichloromethane and the 112 
reaction was continued for 60 min at 5 °C with continuous vigorous stirring. At the end of 60 min the reaction mixture 113 
was centrifuged at 4000 rpm for 5 min. The organic phase was separated and the buffer fraction was repeatedly washed 114 
with dichloromethane (500 µL x 3 times). The adduct identification was based on the observation of the molecular ion 115 
and at least one fragment specific for the analyte after injection in the LC-HRMS system, according to the guidance 116 
document on identification of mycotoxins in food and feed (European ECCommission 2016). Due to the difficulties in 117 
assessing the concentration level of the synthetized adduct, the diluted buffer fraction was used for testing the IAC cross 118 
reactivity during method development and for a qualitative evaluation of presence/absence in the collected urine 119 
samples. 120 
 121 
Study design 122 
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The investigation was conducted in the same feedstuff plant involved in the first study previously published by Ferri et 123 
al. (2017). This second study was conducted within the framework of a larger project entitled “Biomonitoring data as a 124 
tool for assessing aflatoxin B1 exposure of workers – BIODAF” supported by EFSA (July 2017 - June 2018). The 125 
project focused on aflatoxins and took into consideration urine and serum samples collection and analysis. Two 126 
countries, Italy and Portugal, were involved in this study. The present paper reports the results obtained from the Italian 127 
urine analyses. 128 
Two groups of volunteers were enrolled, the “workers group”, corresponding to all workers in direct contact with some 129 
risky activities such as the downloading of the raw material, its handling and the cleaning procedures; and the “control 130 
group”, which included employees of the same company but designated to perform other activities considered not risky 131 
for the absence of contaminated environmental dusts. The samples were collected on Monday and Friday morning in 132 
one working week, Monday was chosen since it reflects a situation characterized by a preceding two-days washing 133 
period and Friday was selected with the aim to verify a possible accumulation of AFs and consequent intake over the 134 
week of sampling. The urine was collected in the morning and delivered to the medical staff before starting the morning 135 
shift. A total of 61 male volunteers were enrolled (32 workers and 29 controls). The collected urine samples were stored 136 
at -20 °C until analysis. The mean value and range for age and body weight of the enrolled volunteers are reported in 137 
Table 1. 138 
The study was conducted under the supervision of the Local Health Unit of Reggio Emilia and was approved by the 139 
Ethical Committee of the Reggio Emilia province. All urine donors were informed about the purpose of the study and a 140 
formal consent was individually signed prior to inclusion in the study. 141 
 142 
Sample preparation 143 
Dilute&shoot sample preparation 144 
Before analysis, all urine samples were equilibrated to room temperature and homogenized by shaking thoroughly. 145 
Aliquots of 100 µL urine were mixed with 860 µL of H2O LC-MS grade; for quantification purpose 20 µL of U-[13C17]-146 
AFB1 5 ng/mL in acetonitrile and 20 µL of U-[13C17]-AFM1 10 ng/mL in acetonitrile were added to the sample. The 147 
diluted sample was centrifuged for 10 minutes at 3500 x g (RCF) before the injection of 10 µL into the UHPLC-HRMS 148 
system. 149 
 150 
Immunoaffinity clean-up 151 
Before analysis, all urine samples were equilibrated to room temperature and homogenized by shaking thoroughly. 152 
Aliquots of 2 mL urine were mixed with 10 mL of phosphate buffered solution (PBS, pH=7.4) and passed through the 153 
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immunoaffinity column (IAC) for purification (Easy-extract® aflatoxins, from R-Biopharm, Darmstadt, Germany). The 154 
IAC was washed with 30 mL of H2O (10+10+10 mlL), then the toxins were eluted with 1 mL of MeOH (500+500 µL). 155 
Finally, 500 µL of eluted sample were added with 20 µL U-[13C17]-AFB1 2.5 ng/mL in ACN, 20 µL U-[13C17]-AFM1 5 156 
ng/mL in ACN and 460 µL of H2O. A volume of 20 µL was injected into the UHPLC-HRMS system. 157 
 158 
LC-HRMS Analysis 159 
Determination was performed by UHPLC-HRMS analysis. Chromatographic separation was performed using UHPLC 160 
Dionex UltiMate 3000® (Thermo Scientific, San Jose, CA, USA). An Acquity UPLC® BEH C18 column (1.7 µm, 100 161 
× 2.1 mm, from Waters, Milford, MA, USA) was used at a temperature of 40 °C. The flow rate was 0.3 mlL/min, 162 
mobile phases A and B were respectively water and methanol containing 0.002% formic acid (v/v) and 2 mM mmol/L 163 
ammonium formate. The following gradient was applied: 20% B increase to 99% in 10 min, keep isocratic at 99% B for 164 
4 min, from 14 to 14.6 min return to 20% B, and finally re-equilibrate the column at 20% B for 2.4 min. High-resolution 165 
MS analysis was performed using Q Exactive™ Quadrupole-Orbitrap™ equipped with Heated ElectroSpray Ionization 166 
(HESI) source (Thermo Scientific, San Jose, CA, USA). The following ESI (+) parameters were used: source voltage 167 
3.5 kV, in-source CID 18 eV, capillary temperature 320 °C, auxiliary gas heater temperature 350 ° C, sheath gas flow 168 
40, S-lens RF level 75 and auxiliary gas flow 14. The MS acquisition was performed in Full Scan/Data Dependent (full 169 
MS/dd-MS2) for confirmatory purpose. Precursor ion, fragments and collision energy used for the determination of the 170 
selected mycotoxins are reported in Table 2. All analytical batches included analysis of appropriate extraction and 171 
solvent blanks, solvent calibration curves at the beginning and end of the analytical batch, and injection of a calibration 172 
level every 10 sample injections to ensure LC–MS stability throughout the run. For data acquisition and processing, 173 
Xcalibur™ software 4.0.27.19 was used. 174 
 175 
Analytical quantification 176 
For mycotoxins quantification an internal standard (ISTD) approach was adopted. The internal standard for AFB1 and 177 
AFM1 was the 13C isotope labelled molecule in which all carbon atoms are substituted by the stable isotope 13C. Six 178 
points calibration curve was obtained by plotting the response ratio (standard area/13C area) versus the concentration 179 
expressed in pg/mLurine. The concentration ranges covered for dilute&shoot method were 5-100 pg/mL for AFB1 and 180 
10-200 pg/mL for AFM1, corresponding to 50-1000 pg/mLurine and 100-2000 pg/mLurine for AFB1 and AFM1, 181 
respectively. For IAC method the ranges were 5-50 pg/mL for AFB1 and 10-100 pg/mL for AFM1, corresponding to 182 
2.5-25 pg/mLurine and 5-50 pg/mLurine for AFB1 and AFM1, respectively. The calibration curve was obtained by fitting 183 
the data with a linear regression model based on least squares method. 184 
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 185 
Validation criteria 186 
Identification criteria were set for all the analysed mycotoxins. Linearity and limit of detection (LOD) and 187 
quantification (LOQ) of the analytical methods were assessed. Precision and trueness were assessed from repeated 188 
analyses on spiked blank urine samples. Precision was evaluated by calculating the intermediate relative standard 189 
deviation (repeated analyses on different days), while trueness was estimated in terms of apparent recovery (RA). 190 
Extraction efficiency (RE) and matrix effect (SSE) were also evaluated for validation purpose. 191 
 192 
Method validation 193 
For both methods, linearity of the method was evaluated from six points calibration curves injected in triplicate for three 194 
consecutive days. Regression lines were plotted applying a linear regression model based on least squares method. The 195 
linearity was assessed by visual checking of the residual plot of response ratios (plotted in y-direction) versus the 196 
respective concentration levels (plotted in x-direction). The final estimated linearity model was verified using the lack-197 
of-fit test (significance of the test with pvalue below 0.05), to confirm that the selected regression and linearity were 198 
acceptable. Once visual checking of the residual and lack-of-fit test passed, the R squared coefficient was taken as a 199 
measure of linearity. 200 
According to the criteria reported in the SANTE/12089/2016 guidance document  on identification of mycotoxins in 201 
food and feed (European Commission 2016), the retention time (RT) of the analyte in the sample extract should 202 
correspond to that of the average of the calibration standards measured in the same sequence with a tolerance of ± 0.1 203 
min. Moreover, for the ISTD added to the sample extract, the RT of the analyte should correspond to that of its labelled 204 
ISTD with a tolerance of ±0.05 min. For HRMS analysis identification is based on observation of the molecular ion (or, 205 
if not available, adducts) and one fragment that is specific for the selected analyte. 206 
According to Wenzl et al. (2016), spiked blanks approach was used for LOD and LOQ assessment, by analysing the 207 
spiked sample in ten replicates under repeatability conditions. The variability expressed as standard deviation obtained 208 
for the ten analyses of spiked blanks was used for the estimation of the critical value of LOD. Calculations were carried 209 
out according to Equation 1 and 2. 210 
 211 
𝑥𝐿𝑂𝐷 = 3.9 ×
𝑠𝑦,𝑏
𝑏
 (1) 212 
𝑥𝐿𝑂𝑄 = 3.3 × 𝑥𝐿𝑂𝐷  (2) 213 
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The LOQ values obtained with the theoretical calculation approaches were included in the validation as the lowest 215 
concentration level. 216 
For dilute&shoot method, the matrix effect was examined according to Sulyok et al. (2006) assessing the matrix 217 
induced enhancement or suppression during analysis. For this purpose, calibration curves in solvent (5 calibration points 218 
in the range of 40-200 pg/mL for AFB1 and 80-400 pg/mL for AFM1, constructed by plotting signal intensity versus the 219 
analyte concentration) were compared with matrix-matched calibration curves (blank sample 1:10 diluted spiked at 5 220 
levels, curves obtained by plotting the signal intensity against the actual spiking level). The slopes of the resulting 221 
calibration curves were used for signal suppression/enhancement (SSE) calculation (Equation 3). 222 
 223 
SSE(%) = 100 ∗
slope (matrix−matched standard)
slope (solvent standard)
  (3) 224 
 225 
For IAC method, apparent recovery, matrix effect and extraction recovery were assessed on 5 different levels of 226 
contamination, including the calculated LOQ values, for each level triplicate analyses of spiked blank sample on 2 227 
consecutive days were performed. The obtained data were used for apparent recovery (RA), matrix effect and extraction 228 
recovery (RE) calculations and for precision assessment. The RA is calculated as the ratio between the slope of the 229 
spiked sample curve, obtained from the spiked samples, and the slope of the calibration curve in pure solvent (Equation 230 
4). In this case, the curves were obtained considering the area and not the ratio with the labelled internal standard added 231 
for each mycotoxin. The RA represents the influence of the whole analytical process (sample preparation + 232 
determination) on the signal and it is also referred to as overall or total recovery of a method. RA was the parameter 233 
used for trueness evaluation. 234 
 235 
RA(%) = 100 ∗
slope (spiked sample)
slope (solvent standard)
  (4) 236 
 237 
The matrix effect was evaluated in terms of Signal Suppression/Enhancement (SSE) and it was calculated, according to 238 
Equation 5, as the ratio between the mean area of the labelled ISTD in the spiked sample extract and in the pure solvent 239 
standard solution. 240 
 241 
𝑆𝑆𝐸 (%) = 100 ×
𝑎𝑟𝑒𝑎 𝑈−[13𝐶17]−𝐴𝐹𝐵1𝑠𝑎𝑚𝑝𝑙𝑒
𝑎𝑟𝑒𝑎 𝑈−[13𝐶17]−𝐴𝐹𝐵1𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑
  (5) 242 
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The RE, accounting to incomplete extraction of the analyte from the matrix, was calculated from RA and SSE, according 244 
to Equation 6. 245 
 246 
RE(%) = 100 ∗
RA
SSE
  (6) 247 
 248 
The effect of random errors on the measurements were assessed and quantified as the relative standard deviation (RSD) 249 
of repeated independent analyses conducted in intermediate conditions of repeatability within the laboratory (RSDLR). 250 
Instrumental laboratory reproducibility of the LC-HRMS system was also evaluated by injecting on three consecutive 251 
days (inter-run) and in replicates (intra-run) a neat solvent standard solution (AFB1 150 pg/mL and AFM1 300 pg/mL). 252 
Moreover, the intermediate precision of the whole method was evaluated by analyzing daily independent urine sample 253 
spiked at the same contamination level as an internal control sample (inter-day). The performance criteria for precision, 254 
quantified with standard deviation of repeatability within the laboratory (sLR) and expressed in percentage as RSDLR, 255 
was set at 15% of variability, including any source of instrumental and analytical possible random errors. Precision was 256 
estimated in terms of intermediate precision RSDLR of repeatability. 257 
 258 
Results and Discussion 259 
Sample preparation and LC-HRMS analysis 260 
During method set up two urine:water dilution factors, namely 1:5 and 1:10, were tested for dilute&shoot approach. The 261 
1:10 dilution gave better results in terms of SSE and was selected for the analysis. The IAC purification step was 262 
introduced in order to reduce the LOD/LOQ values. The employed IAC contains specific antibodies to aflatoxins B1, 263 
B2, G1, G2 and M1, no specific information werewas given by the supplier for AFB1-N7-Guanine. To evaluate the risk of 264 
adduct loss during purification, the synthetized adduct was applied to the IAC, eluted according to method protocol and 265 
the presence of the adduct was confirmed by LC-HRMS identification. 266 
HRMS conditions were set by direct infusion of standard solution for AFB1 and AFM1, while for AFB1-N7-Guanine the 267 
selection of collision energy and specific fragments were guided by the work of Walton et al. (2001). AFB1 produces 268 
sodiated adduct in a non negligible amount when compared with protonated adduct during electrospray ionization step, 269 
although AFB1 is unlikely produce ammonium adduct, the presence of the ammonium in the mobile phase suppresses 270 
the sodiated adduct in favour of the protonated one. This is the reason for the presence in the mobile phases of formic 271 
acid and ammonium formate. For quantitative purpose the protonated adducts were selected, for AFM1, since it was not 272 
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possible to reduce the sodiated adduct production by varying source parameters, the sum of the protonated and sodiated 273 
adduct was considered. 274 
 275 
Validation parameters 276 
Linearity was checked in the working range by the lack-of-fit test based on the analysis of variance (F test with p value 277 
<0.05) and the plot of the residual values randomly distributed around zero, confirming the linearity. During routine 278 
analytical sessions an R2 >0.990 was set as a criterion for calibration curve acceptability. In Table 3 the calibration 279 
curve ranges, the amount of ISTD added to each calibration level and the correlation coefficients (R2) obtained for each 280 
mycotoxin/matrix combination are reported. 281 
The performance characteristics, in terms of RA, SSE and RE, are summarized in Table 4 together with LOD and LOQ 282 
values and the working range of the two analytical procedures. Both methods may be applied for quantitative analysis 283 
of AFB1 and AFM1 as well as for the evaluation of presence/absence of the AFB1-N7-Guanine adduct. The dilute&shoot 284 
method is characterized by higher LOD and LOQ values when compared with the IAC clean-up method, but on the 285 
other hand the dilute&shoot approach is very quick and characterized by a conservative approach with respect to the 286 
sample, giving the possibility of a retrospective analysis on the acquired data. Due to the absence of a sample pre-287 
treatment only matrix effect, in terms of SSE, and precision, in terms of RSDLR, were evaluated during dilute&shoot 288 
method validation. SSE percentages are very close to 100% due to the dilution applied to the urine sample; method 289 
precision was assessed by performing 8 independent analyses at the LOQ level. The IAC clean-up method was fully 290 
validated, trueness was evaluated in terms of apparent recovery (RA) while precision was assessed by laboratory 291 
reproducibility RSDLR measures. Although the IAC clean-up, which is a very selective approach, was used, the 292 
influence of the matrix was also evaluated, and the percentages of SSE for AFB1 and AFM1 found confirmed that the 293 
influence of the matrix on the instrumental response is very limited.  294 
LOD and LOQ of analytical methods always represent a challenge being the bottleneck for the reliability of the 295 
analytical results and also for the further processing of the findings (i.e. data mining). Modern HRMS instruments 296 
makes it possible to reach high sensitivities with low detection limits, and especially when methods are targeted, good 297 
benchmarks can be achieved. Among the most recent studies on the biomonitoring of aflatoxins, the lowest values for 298 
AFM1 were found in the range of 0.13-0.6 pg/mLurine and in the 0.4-1.8 pg/mLurine for LOD and LOQ, respectively 299 
(Giolo et al. 2012; Romero et al. 2010). Although these values represent a gold standard benchmark, they are not 300 
covered by the strict performance requirements of accuracy, which instead were met at 10 pg/mLurine (Giolo et al. 2012) 301 
and 4 pg/mLurine (Romero et al. 2010). Thus, the LOD/LOQ values obtained in the IAC method, validated under strict 302 
performances, are in alignment with the findings in other bomonitoring works for AFM1. Notwithstanding, all the 303 
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positive samples were in the range of values between LOD and LOQ, revealing the crucial need to stress the method to 304 
reach lower levels. In conclusion, the general validation results obtained in this study are considered satisfactory either 305 
for screening and for confirmation and the method is considered to suit for the production accurate data for 306 
biomonitoring purposes. 307 
 308 
Analytical results 309 
Statistical analysis and Data handling - Left censored data 310 
The hypothesis of normal distribution (Shapiro–Wilk test) was refused, thus non-parametrical tests were used for the 311 
statistical treatment of the analytical results. All possible differences between concentration levels of mycotoxins in 312 
exposed and non-exposed groups were explored by a Wilcoxon rank-sum test. To assess the correlation between 313 
mycotoxin levels, a Spearman’s rank correlation coefficient (or Spearman’s rho) was used. All tests were conducted 314 
with a level of significance of 5%. Analyses were conducted by means of STATA14 software (Stata/IC 14.0, Copyright 315 
1985–2015 StataCorp LP). Under the rigid identification criteria for analyte determination, namely the RT criteria 316 
(RT±0.1 min with respect to the standard RT) and the presence of the precursor ion and at least one characteristic 317 
fragment for each considered analyte, it was decided to include and report also all the values below LOQ obtained by 318 
the interpolation of the calibration curve. Thus, values lower than LOQ were reported in the dataset as positive samples 319 
provided that the identification criteria were met. The results evaluation included also the reporting of the lower and 320 
upper bound (LB and UB) mean values (EFSA 2010). These values were calculated applying a substitution method for 321 
which in the LB calculations the results lower than LOQ were substituted with zero, while in the UB the results lower 322 
than LOQ were substituted with LOQ value depending on the method. 323 
 324 
Analysis of samples 325 
The collected urine samples were analysed first with the dilute&shoot method, through which none of the sample 326 
showed a measurable level of AFB1 or AFM1, including AFB1-N7-Guanine which was not detected. To overcome the 327 
limitations coming from the detection limit threshold of the dilute&shoot method and verify that the negativity of the 328 
results could be caused by the level of LOD/LOQ declared, it was decided to set up and validate a method with lower 329 
LOQ. A purification step was introduced using an IAC clean-up to clean and concentrate the urine sample. By using 330 
this method for reprocessing the urine samples, AFB1 and its adduct were not detected, AFM1, instead, was found in 14 331 
samples (12%) within the range 1.9-10.5 pg/mLurine. Only one sample, coming from the workers’ group, showed a value 332 
above the LOQ (10.5 pg/mLurine) and it is a sample from the workers group. Tables 5 and 6 summarize the percentages 333 
of positive samples, maximum values found, and mean values (LB-UB) for worker and control groups, respectively. It 334 
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should be noted that when values reported for AFM1 are below the LOQ they were considered as affected by a standard 335 
uncertainty higher than 25%, which was the performance criteria set for maximum standard uncertainty for the LOQ. 336 
The LB-UB values reflect the optimistic and pessimistic scenario range of possible mean values. 337 
Figure 1 shows the data trend for AFM1 in urine for both groups, Monday and Friday sampling. On the left side LB 338 
substitution method was applied, due to the high number of non-detected (87%), box plot is flattened to zero. On the 339 
right side the box plot reports all the positive values are reported. The band inside the box is the second quartile (P50, 340 
median). Dots indicates suspected outliers. Whiskers are set from minimum to maximum value. First and third quartiles 341 
(P25 and P75) can be found at the bottom and the top of the box, respectively. 342 
No statistical difference for AFM1 was observed between Monday and Friday samples in each group (exposed and non-343 
exposed workers). To note that among the positive results two individuals of the exposed workers group showed AFM1 344 
in both Monday and Friday deliveries (3.3 and 3.0 pg/mlLurine and 4.6 and 10.5 pg/mLlurine, Monday and Friday values 345 
for each individual, respectively. Further statistical analyses were performed merging data of Monday and Friday data 346 
(63 analyses for exposed workers group and 57 for non-exposed workers group). Eight samples (13%) resulted positive 347 
in the workers’ group where the highest contaminated sample was found (10.5 pg/mlLurine); six samples (11%) were 348 
positive in the control group, the higher detected value was 4.1 pg/mlLurine. In order to find differences among the 349 
positive values found in workers and control group, a Wilcoxon rank-sum test was performed but no statistical 350 
significances were highlighted; even exploring the two days of urine delivery, no differences were highlighted. 351 
The absence of AFB1 and its adduct, together with the absence of a statistical difference when the mean values of AFM1 352 
for workers and control groups were compared, suggests that in this specific setting, no professional exposure occurs. 353 
Moreover, considering the very low level of AFM1 in the collected urine samples, also the contribution from the diet to 354 
the overall exposure is to be considered negligible.  355 
Conclusions 356 
This study presents a method, performed by a high-resolution mass spectrometry (LC-HRMS) technique, to detect 357 
AFB1 and aflatoxin biomarkers, namely AFM1 and aflatoxin-N7-Guanine. If compared with the previous study 358 
conducted in 2014 (Ferri et al. 2017), the present work tackles with an improvement of method sensitivity (1.5 359 
pg/mlLurine versus 25 pg/mLlurine in Ferri et al. (2017). High percentages of workers positive for AFB1 were reported in 360 
several studies conducted in EU (Portugal, Italy, Denmark) (Olsen et al. 1988; Viegas et al. 2018; Ferri et al. 2017) 361 
emphasizing that occupational exposure might be critical in certain settings, such as feed plants, in which indoor areas 362 
can be conducive of highly contaminated dust particles. In this study, morning urine samples were collected during one 363 
working week from a cohort of occupational exposed workers of a feed company and from a control group. The 364 
presence of only one positive sample of AFB1 and the lack of statistical difference between mean values of AFM1 in 365 
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workers and control groups, suggests that in this specific setting, the primary route of exposure to AFs is more likely to 366 
be attributed to the diet and not to the respiratory route when inhalation or dermal contact of aerosolized contaminated 367 
dusts occur. However, the attention and focus to AFs can’t never be reduced to a no-risk situation, since, due to the 368 
direct correlation between aflatoxins occurrence and climate changes, a systematic monitoring of the health status of 369 
citizen (including workers) potentially exposed to dusts contaminated by these toxic compounds, has to be duly 370 
undertaken. 371 
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 508 
Figure 1 Data trend for AFM1 in urine for exposed and control groups. Left side, mean LB values; right side, mean 509 
positive values. The horizontal band (inside the box) is the second quartile (P50, median). Dots are suspected outliers. 510 
Whiskers are set from minimum to maximum value. The bottom and the top of the box are the first and third quartiles 511 
(P25 and P75). 512 
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Table 1. Distribution of the enrolled volunteers by group, age and body weight 541 
Volunteers Number of subjects Mean age (range); years Mean body weight (range); kg 
Workers group 32 53 (32–-65) 80.1 (62–-99) 
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Controls group 29 48 (33–-63) 83.4 (64–-125) 
Total 61 - - 
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Table 2 Precursor ion, fragments and collision energy used for the detection of the selected mycotoxins in 569 
urine samples 570 
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Compound Chemical formula Precursor ion (m/z) [M+H]+ Fragment (m/z) NCEa 
AFB1 C17H12O6 313.07066 285.07571; 241.04952 25 
13C17-AFB1 C17H12O6 330.12770 - - 
AFM1 C17H12O7 329.06558 + 351.04752b 273.07538; 229.04937 27 
13C17-AFM1 C17H12O6 346.12261 + 368.10456b - - 
AFB1-N7-Guanine C22H17N5O8 480.11499 152.05678, 165.05499 40; 90 
aNormalised Collision Energy; b[M+Na]+ 571 
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Table 3 Calibration curve range, labelled internal standard concentration and correlation coefficients 596 
obtained for each mycotoxin/matrix combination are reported 597 
Method 
Calibration curve range 
(pg/mlL) 
Labelled standard 
(pg/mlL) 
R2 (RSD, %) 
 AFB1 AFM1 U-[13C17]-AFB1 U-[13C17]-AFM1 AFB1 AFM1 
Dilute&shoot 5– – 100 10– - 200 10 20 0.9965 (0.04) 0.9967 (0.20) 
IAC 2.5 –- 50 5– - 100 50 100 0.9973 (0.09) 0.9976 (0.10) 
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Table 4 Performance characteristics obtained during validation for AFB1 and AFM1 in urine with 622 
dDilute&shoot -and-Shoot and IAC clean-up methods 623 
 DDilute&shoot method IAC clean-up method 
 AFB1 AFM1 AFB1 AFM1 
LOD (pg/mlLurine) 20 40 0.8 1.5 
LOQ (pg/mLlurine) 50 100 2.5 5.0 
Working range 
(pg/mLlurine) 
50.0 – 1000.0 100.0 – 2000.0 2.5 – 25.0 5.0 – 50.0 
RA (%) - - 101 98 
RE (%) - - 97 92 
SSE (%) 82 111 104 107 
RSDr (%) 8 11 6 12 
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Table 5. Percentage of positive samples, maximum values found and mean values (LB-UB) for AFM1 in workers group 646 
samples 647 
 Positivea (%) Maxb (pg/mLurine) Mean (LB-UB) (pg/mLurine) 
Monday and Friday; subjects (n=63) 13 10.5 0.5-4.9 
Monday; subjects (n=32) 13 4.6c 0.4-4.48 
Friday; subjects (n=31) 13 10.5 0.6-5.0 
aPositive: values above LOD 648 
bMax: maximum value 649 
cvalue below the LOQ 650 
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Table 6. Percentage of positive samples, maximum values found and mean values (LB-UB) for AFM1 in controls group 675 
samples 676 
 Positivea (%) Maxb (pg/mLurine) Mean (LB-UB) (pg/mLurine) 
Monday and Friday; subjects (n=57) 11 4.1 0.3-4.8 
Monday; subjects (n=29) 7 2.8c 0.2-4.8 
Friday; subjects (n=28) 14 4.1c 0.4-4.7 
aaPositive: values above LOD 677 
bMax: maximum value 678 
cvalue below the LOQ 679 
 680 
b 681 
c 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9
10 
11 
12 
13 
14 
15
16
17 
18
19
20 
21 
22
23 
24 
25
26 
27 
28
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3RD REV (letter 19/12/2019) 
Reviewers' comments: 
1. Delete heading "Conclusions", this journal has no such section. Concluding remarks should 
be put directly after end of results and discussion. DONE 
2. Do not use justified text, but type left-aligned throughout the manuscript without 
automated hyphenation (?). Then please check if some typos (extra space etc) become 
visible and correct im necessary. DONE 
3. Move "Acknowledgements" section directly before the reference list section DONE 
4. Temperature and other units: consistently add one space between number and unit, for 
example "2 °C". Only % should be placed directly at the number, for example "98.3%" DONE 
5. Consistently use only SI units, for example L119 100 mmol/L phosphate, and look for other 
occurrences as well. DONE 
6. L124 what does "Guanine dissolved in 0.1 N HCl (0.32 μmoles)" mean? a "mol" has no 
plural, just numbers. Replace N with mol/L DONE 
7. Check reference list again carefully and correct/modify according to examples as given in 
the instructions for authors of this journal (for example, EU regulations, EC-regulations, FAO 
documents). Remove issue numbers in brackets, not necessary. At present, reference list is 
full of typos etc. NO capitals in reference text except first word. DONE 
8. Figure legends should be placed on a separate page not directly at figures. There is a 
supplementary file in the first revision named capture list but this appears to be empty. 
Please place list of figure captions after the references on a separate page in the 
manuscript, before the tables. DONE 
9. Tables: just 3 horizontal lines, one above and one below the main table body, and one 
separating the first parameter row from the data entries. No extra horizontal lines in the 
main table body. Tables 1 and 2 are ok. DONE 
Authors' Response to Reviewers' Comments Click here to access/download;Authors' Response to
Reviewers' Comments;Reviewers_3RD REV.docx
Figure 1  
 
 
Figure
Dear Editor 
Please find enclosed the revision of the research paper entitled “Optimization and validation of 
a LC-HRMS method for aflatoxins determination in urine samples” done following the 
comments from reviewers (letter 19 Dec 2019). 
I thank you again for the opportunity to publish the manuscript in your respected journal. 
Sincerely yours 
Barbara De Santis 
Cover Letter
